Table 1.
PATIENT | |
---|---|
Mean age at diagnosis – year (SD, range) | 36.69 (15.19, 18–69) |
Female gender – no. (%) | 34 (68%) |
TUMOR | |
Location – no. (%) | |
Spine | 3 (6%) |
Intracranial | 47 (94%) |
Hemispheric | 16 (32%) |
Sellar | 23 (46%) |
Pineal | 3 (6%) |
Thalamus | 1 (2%) |
CP angle | 3 (6%) |
Cerebellum | 1 (2%) |
Dissemination – no. (%) | 14 (28%) |
Composite tumor – no. (%) | 6 (12%) |
TREATMENT | |
Surgery – no. (%) | |
Gross total resection | 12 (24%) |
Incomplete resection | 21 (42%) |
Biopsy | 1 (2%) |
Not reported | 16 (32%) |
Adjuvant therapy – no. (%) | |
Radiotherapy and chemotherapy | 28 (56%) |
Radiotherapy only | 8 (16%) |
Chemotherapy only | 1 (2%) |
Stereotactic radiosurgery | 2 (4%) |
None | 4 (8%) |
Not reported | 7 (14%) |
PROGNOSIS | |
Alive at follow-up – no. (%) | 17 (34%) |
Mean follow-up – months (SD, Range) | 42.53 (48.09, 4–204) |
Death – no. (%) | 31 (62%) |
Mean time to death – months (SD, Range) | 20.34 (35.44, 0–168) |
CP angle, cerebellopontine angle.